Hansa On a High After CHMP Thumbs-Up For Idefirix
Positive Opinion For Kidney Transplant Drug
Sweden's Hansa Biopharma has taken an important step closer to becoming a commercial-stage company with the backing of European regulators for Idefirix, although launch plans have been impacted by the COVID-19 crisis.
